Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Accelerate Global Agreement to Oversee Exploitation of South Pole “Extremophiles”

02.02.2004


Ownership of genetic materials, environmental consequences in question as 21st Century bio-prospecting gets underway in Antarctica



Work should be stepped up on international agreements to oversee prospecting efforts in Antarctica by research institutions, universities and pharmaceutical companies to discover and stake ownership to promising organisms and compounds with genetic properties that make survival possible in extremely cold, arid and salty conditions, says a new UN University report.

Bioprospectors are starting to turn their attention to many of the world’s last frontiers, such as hydrothermal vents, the deep seabed, the water column of the high seas and polar ice caps. Indeed, according to the report[1], these frontiers have the potential to create a 21st Century “gold rush” – with bioprospectors trying to find and exploit the unique genetic and biochemical riches of “extremophiles,” organisms that have evolved unique characteristics to survive in Earth’s most hostile environments.


Many scientists believe that isolating and extracting the substances that allow these organisms to prosper could have enormous implications in biotechnology research, possibly leading to new cancer treatment drugs, antibiotics and industrial compounds.

But in fragile Antarctica this optimism is offset by warnings of significant consequences if an unregulated international “free-for-all” is allowed to develop.

“Biological prospecting for extremophiles is already occurring and is certain to accelerate in Antarctica and the southern oceans,” said Dr. A.H. Zakri, Director of UNU’s Institute of Advanced Studies, the Tokyo-based research center that conducted the study.

“This report suggests that efforts to exploit this new frontier are now threatening to outpace the capacity of national and international law to regulate such things as ownership of genetic materials, the issuing of patents on products that may arise from them, and the potential environmental consequences of harvesting these resources.”

The information is being released on the eve of a major global biodiversity meeting expected to attract more than 2,500 global officials and experts to Kuala Lumpur Feb. 9 to 20: the 7th Conference of Parties to the UN Convention on Biological Diversity. The extremophiles report was undertaken as part of a wide-ranging UNU-IAS initiative to help foster and support global “biodiplomacy[2].”

So far, the report says, biological prospecting in Antarctica has usually been carried out by consortia made up of public and private bodies, principally universities, research centers and biotechnology and pharmaceutical companies. This has made it difficult to draw a clear line between scientific research and commercial activities, although it is clear that much of the recent activity has led to commercial applications.

One of these is a glycoprotein, which functions as the ‘antifreeze’ that circulates in some Antarctic fish, preventing them from freezing in their sub–zero environments. It was discovered in the early 1970s by University of Illinois scientists conducting research funded by the US National Science Foundation.

The glycoprotein has a range of potential applications, including increasing the freeze tolerance of commercial plants, improving farm–fish production in cold climates, extending the shelf life of frozen food, improving surgery involving the freezing of tissues, and enhancing the preservation of tissues to be transplanted.

A preliminary scan of the US Patent Office database identified more than 300 references to Antarctica and 92 applications for patents that referred to Antarctica. A similar survey of European Patent Office records turned up 62 patents that rely on Antarctic biodiversity.

Some recent examples:
  • In 2002, Spain granted a patent for the wound healing and skin, hair and nail treatment properties of a glycoprotein extracted from an Antarctic bacteria;
  • The same year, an extract from an Antarctic green algae was patented in Germany for use in cosmetic skin treatment;
  • In 1997, a patent was granted by the Russian patent office for the production of biologically active substances with anti–tumour properties extracted from a strain of Antarctic black yeast;
  • An application currently with the US Patent Office covers a process for producing anti-freeze chemicals discovered in Antarctic bacteria which may help to increase the shelf life of foods such as ice-cream and frozen vegetables.

The report notes that developing commercial products from naturally occurring genetic resources or biochemical processes is typically a long, expensive and uncertain process. Even so, annual sales derived from traditional knowledge using genetic resources are $3 billion for the cosmetics and personal care industry, $20 billion for the botanical medicine sector and $75 billion for the pharmaceutical industry. More than 60 percent of the cancer drugs approved by the US Food and Drug Administration are of natural origin or are modeled on natural products.

“Although there has been a recent downturn in bioprospecting overall, it seems that the commercial use of naturally occurring extremophiles will increase, perhaps dramatically, in the near future,” said Hans van Ginkel, Rector of UN University.

“This study shows that the world must be better prepared for this, especially with respect to the Antarctica. Many issues and questions need to be resolved in advance of the further exploitation of genetic resources at the pole.”

UNU-IAS researcher Sam Johnston, report co-author, said the Antarctic Treaty System (ATS), the principal international agreement governing activity on the continent, does not specifically regulate bio-prospecting. Moreover, international policies governing bio-prospecting elsewhere are of limited value in addressing these questions.


Among the key issues not addressed by the ATS:

  • Who owns the Antarctic genetic resources?
  • How can scientists working in the Antarctic Treaty area legitimately acquire these resources?
  • What measures do scientists have to take to protect these resources?
  • Is benefit sharing feasible and, if so, with whom?
  • Who owns the commercial products resulting from these resources?
  • What is the relationship between the ATS and other international agreements e.g. the Convention on Biological Diversity (CBD) and the UN Convention on the Law of the Sea (UNCLOS)?
  • Does bio-prospecting contravene Article III of the ATS which stipulates that:
    • Information regarding plans for scientific programs in Antarctica should be exchanged.
    • Scientific personnel should be exchanged between expeditions and stations.
    • Scientific observations and results should be exchanged and made freely available.

The report concludes that although the physical impact of bioprospecting is currently addressed by the ATS regime, establishing the legal and policy basis that controls the commercialization of genetic resources, in line with the basic principles of the ATS as well as equity and fairness, is a more complex matter.

“Indeed, developing measures on bioprospecting in Antarctica would require some basic conceptual agreement about the overall aims of any regulation and the type of management system that is desirable, feasible, practical, and equitable.”

The study recommends further analysis and research with the emphasis on:

  • Information about existing and planned bio-prospecting activities in Antarctica.
  • Information on current and planned commercially orientated research involving Antarctic biota.
  • A working definition of bio-prospecting.
  • The legal issues relating to the ownership and protection of these resources?
  • Who owns the commercial products resulting from the resources?
  • Is benefit sharing feasible and if so with whom?
  • The relationship between the ATS and other international policies.
  • Is bio-prospecting contrary to Article III of the Treaty?
  • Preliminary views about the need for regulation or guidelines.

Terry Collins | UN University
Further information:
http://www.unu.edu/news/extremophiles.html

More articles from Studies and Analyses:

nachricht Win-win strategies for climate and food security
02.10.2017 | International Institute for Applied Systems Analysis (IIASA)

nachricht The personality factor: How to foster the sharing of research data
06.09.2017 | ZBW – Leibniz-Informationszentrum Wirtschaft

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>